4.6 Article

Upgrading two-stage membrane bioreactor by bioaugmentation of Pseudomonas putida entrapment in PVA/SA gel beads in treatment of ciprofloxacin

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ibiod.2016.10.020

关键词

Antibiotic; Bioaugmentation; Ciprofioxacin; Entrapped cells; Pseudomonas putida; MBR

资金

  1. ASEAN University Network/Southeast Asia Engineering Education Development Network (AUN/SEED-Net) [KU CRI 1501]
  2. KWEF-AIT

向作者/读者索取更多资源

The laboratory scale of the two-stage membrane bioreactor (2S-MBR) was investigated to find the optimal hydraulic retention times (HRT) in treatment of selected 10 antibiotics in real hospital wastewater. It showed that elimination of the antibiotics varied, depending upon antibiotic types and HRT. High biodegradation attributed to amoxicillin and clarithromycin. Fluoroquinolones/tetracycline adsorbed highly on anoxic (ANX) sludge, but tended to be biodegraded in the aerobic tank. Sulfamethoxazole/ trimethoprim were mainly accumulated in the ANX/aerobic sludge. In order to increase biodegradation, 2S-MBR was upgraded to a three-stage MBR (3S-MBR) using the polyvinyl alcohol and sodium alginate (PVA/SA) beads of Pseudomonas putida (TISTR1522) in an entrapped cells reactor (ECR) as a pretreatment unit. Ciprofioxacin (CIP) in a synthetic wastewater was a refractory antibiotic for this feature investigation. It showed improvement of CIP degradation reached to 90% in 3S-MBR as compared to 58% of 2S-MBR. As a result, 24 CIP-transformed products (TPs) were detected. Additionally, 3S-MBR showed better efficacy of nitrogen removals. The SEM and FISH techniques revealed bacterial consortium in the system showing that the beads were well supported P. putida growth as well as synchronizing volume available for other bacteria. This feature makes P. putida being a potential microorganism for CIP biodegradation via bioaugmentation in 3S-MBR. (C) 2016 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据